MORGAN STANLEY - APTOSE BIOSCIENCES INC ownership

APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 56 filers reported holding APTOSE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of APTOSE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$450,107
+11.6%
703,292
+1.1%
0.00%
Q4 2022$403,399
-12.3%
695,515
-10.0%
0.00%
Q3 2022$460,000
-34.0%
772,553
-17.7%
0.00%
Q2 2022$697,000
-40.3%
938,717
+9.4%
0.00%
Q1 2022$1,167,000
-34.4%
858,284
-34.8%
0.00%
Q4 2021$1,779,000
-45.1%
1,317,291
-11.4%
0.00%
Q3 2021$3,242,000
+63.5%
1,487,428
+149.1%
0.00%
Q2 2021$1,983,000
-34.6%
597,180
+17.8%
0.00%
Q1 2021$3,030,000
+45.9%
507,051
+6.9%
0.00%
Q4 2020$2,077,000
-25.7%
474,221
+1.8%
0.00%
-100.0%
Q3 2020$2,796,000
+31.4%
466,030
+38.2%
0.00%
Q2 2020$2,128,000
-11.9%
337,187
-17.1%
0.00%
-100.0%
Q1 2020$2,416,000
-5.0%
406,665
-9.3%
0.00%0.0%
Q4 2019$2,542,000
+228.8%
448,510
+21.0%
0.00%
Q3 2019$773,000
-6.2%
370,791
+17.5%
0.00%
Q2 2019$824,000
+56.7%
315,521
+20.7%
0.00%
Q1 2019$526,000
-26.9%
261,321
-30.6%
0.00%
Q4 2018$720,000
-35.1%
376,421
-11.8%
0.00%
Q3 2018$1,110,000
-22.0%
426,987
+18.1%
0.00%
Q2 2018$1,423,000
+151.4%
361,471
+101.6%
0.00%
Q1 2018$566,000
+328.8%
179,271
+204.7%
0.00%
Q4 2017$132,000
+144.4%
58,828
+61.9%
0.00%
Q3 2017$54,000
+671.4%
36,332
+568.9%
0.00%
Q2 2017$7,000
-41.7%
5,432
-50.0%
0.00%
Q1 2017$12,000
-25.0%
10,8640.0%0.00%
Q4 2016$16,000
-20.0%
10,864
+21.6%
0.00%
Q3 2016$20,000
+11.1%
8,932
+22.4%
0.00%
Q2 2016$18,000
+800.0%
7,300
+913.9%
0.00%
Q1 2016$2,0000.0%720
+16.1%
0.00%
Q4 2015$2,000
-33.3%
620
+3.3%
0.00%
Q3 2015$3,0000.0%600
-3.4%
0.00%
Q2 2015$3,0000.0%621
+0.2%
0.00%
Q1 2015$3,000620
+3000.0%
0.00%
Q4 2014$0200.00%
Other shareholders
APTOSE BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Annandale Capital, LLC 74,666$2090.05%
CALDWELL SUTTER CAPITAL, INC. 92$2580.00%
View complete list of APTOSE BIOSCIENCES INC shareholders